Presenting at CMSC 2022, researchers investigated the effects of weight training on bone density, quality of life, and cognition in patients with MS.

Presenting at CMSC 2022, researchers examined the use of powered exoskeletons for gait training, assessing practicality, safety, and clinical outcomes in patients with MS.

The researchers sought to examine the correlation between physical activity measured by a device and cognitive outcomes based on neuropsychological testing in patients with MS who were prescreened for cognitive impairment.

Researchers sought to characterize the prevalence and clinical features of individuals with both MS and INO in a population-based cohort of patients with MS.

Researchers sought to assess the change in blood pressure in patients with MS treated with ATZ and prior HDMP treatment compared with patients receiving HDMP only for acute relapse.

In a prospective cohort study, researchers assessed whether adverse childhood experiences may increase the risk for multiple sclerosis in women.

Researchers sought understand the genetic predisposition and environmental factors on monozygotic twin pairs discordant for MS.

Researchers sought to assess the applicability of sNfL to identify people at risk for future disease activity at the group level and in individuals with multiple sclerosis.

In a longitudinal study, researchers aimed to identify the presence of CVS in new white matter lesions in patients with MS and investigate demographic and clinical risk factors associated with CVS development.

In a systematic review and meta-analysis, researchers determined the effects of Pilates exercises on balance in people with multiple sclerosis.

Researchers sought to evaluate the ability of 7.0-T MSRI in depicting and visualizing pathologic manifestations in the normal-appearing white matter and cortical gray matter in patients with multiple sclerosis, and how they relate to disability.

In an observational study, researchers studied the role of spinal cord and brain atrophy for silent progression and conversion to secondary progressive multiple sclerosis.

Researchers sought to assess whether COVID-19 infection developed despite of vaccination among patients with multiple sclerosis or neuromyelitis optica spectrum disorder, using a French database of these patient populations.

Using metagenomics, researchers assessed the functional potential of the gut microbiome in patients with pediatric-onset MS and unaffected control individuals using stool samples.

In a systematic review and meta-analysis of longitudinal studies, researchers used neuroimaging for its predictive ability to determine cognitive decline and disability outcomes in MS.

In a prospective and longitudinal cohort study, researchers examined the course of recovery from COVID-19 among patients with MS and sought to identify its predictors, such as patients’ physical and mental health status before COVID-19 infection.

Researchers sought to examine the association between timing and dose of rituximab and hospitalization for COVID-19 in patients with multiple sclerosis in Sweden.

General practitioners may not discuss vision-related quality of life for people with MS, and may infrequently refer them to appropriate care.

Researchers sought to determine the efficacy of COVID-19 mRNA vaccines and immune-specific response of patients with MS treated with various disease-modifying drugs.

Using data from a prospective, international registry, researchers assessed whether delayed-release dimethyl fumarate exposure affects pregnancy and infant outcomes among pregnant women with multiple sclerosis.

In a prospective observational study, researchers investigated the incidence of hypogammaglobulinemia and infections in patients with MS who were treated with rituximab in the MS center of Marseille, France.

Ublituximab is an investigational glycoengineered monoclonal antibody that targets CD20.

Using single molecule array assay, researchers examined sNfL levels of patients with MS who were either on a common diet or ketogenic diet or fasting.

Using MRI rebaselining, researchers sought to assess the efficacy of ocrelizumab in patients with relapsing-remitting multiple sclerosis with a prior poor response to disease-modifying therapies.

The researchers sought to determine the clinical and biochemical features of alemtuzumab-induced autoimmune thyroid events and look their risk factors with a focus on fluctuating Graves’ disease.

In a population-based cohort, researchers assessed whether hospital-diagnosed infectious mononucleosis during childhood, adolescence, or young adulthood is associated with MS diagnosis independent of shared familial factors.

Researchers sought to determine if physical exercise has a positive effect on multiple sclerosis fatigue and which type of exercise has the largest effect on fatigue, also based on disease severity.

Researchers sought to compare short- and long-term outcomes related to memory functions, cognitive abilities, and functional abilities in patients with MS who received memory rehabilitation to those who received no treatment.

Researchers sought to determine the dose-response relationship between tolebrutinib, an oral, CNS-penetrant, irreversible inhibitor of Bruton’s tyrosine kinase, and the reduction in new active brain MRI lesions in patients with relapsing MS.

In a scoping review, researchers sought to describe task-oriented exercises utilized in research regarding patients with multiple sclerosis and examine their effects on motor function that distinguishes them from other types of exercise.